These are valid questions and deserve complete answers
Additionally, individual patient factors including baseline gastric motility, previous gastrointestinal conditions, concomitant medications, and genetic variations in drug metabolismsignificantly influence susceptibility to nausea
We asked nutritionists Some food companies, including Nestle and Conagra, are responding to the popularity of obesity and diabetes drugs by branding some products "GLP-1 Friendly." The labels target a growing number of consumers taking medicines such as Zepbound and Wegovy who may be looking for healthier, ready-made meals that minimize side-effects from the drugs
GLP-1 receptor (GLP-1R) agonists have been introduced for the treatment of type 2 diabetes mellitus 3
At one year, GLP-1 analog monotherapy recipients had a mean weight loss of 11.42 kg, whereas combination treatment patients had an average weight loss of 5.51 kg
Footnotes Hendershot CS, Bremmer MP, Paladino MB, et al